Results 151 to 160 of about 13,246 (200)

A comprehensive evaluation of flap reconstruction in periocular repair: outcomes, complications, and future directions. [PDF]

open access: yesBMC Ophthalmol
Rajabi MT   +7 more
europepmc   +1 more source

Trends in the Incidence of Rare Eyelid Malignancies: A Surveillance, Epidemiology, and End Results-Based Study (2000-2021). [PDF]

open access: yesOcul Oncol Pathol
Yaseen S   +9 more
europepmc   +1 more source

Blepharitis and Neoplasms of the Canine Eyelid Margin and Skin

Veterinary Clinics of North America - Small Animal Practice, 2023
Canine eyelid masses (tumors) should include the differential clinical diagnoses of neoplasia and blepharitis. They have many common clinical signs including tumor, alopecia, and hyperemia. Biopsy and histologic examination remains the most effective diagnostic test to establish a confirmed diagnosis and appropriate treatment.
Bruce Grahn
exaly   +3 more sources

Eyelid Neoplasms of Dogs

American Journal of Veterinary Research, 1975
SUMMARY A survey of 202 canine eyelid neoplasms was conducted to identify the prevalence of tumor types and their biological behavior. Sebaceous gland tumors, melanomas, and papillomas made up 82.1% on neoplasms studied. Sebaceous tumors were most frequently encountered, comprising 44% of canine eyelid tumors.
J D, Krehbiel, R F, Langham
exaly   +3 more sources

Management of Eyelid Neoplasms in the Dog and Cat

Topics in Companion Animal Medicine, 2007
Eyelid neoplasms are common in the older dog and typically benign. Eyelid neoplasms in the cat are less common and more often malignant. Resection of eyelid masses may be curative; however, restoration of the eyelid structure after mass excision is essential for maintaining long-term ocular surface health.
exaly   +3 more sources

Cutaneous Eyelid Neoplasms as a Toxicity of Vemurafenib Therapy

Ophthalmic Plastic and Reconstructive Surgery, 2015
The discovery of BRAF mutation in ~50% of melanomas led to the development of small molecule BRAF inhibitors, including sorafenib, debrafenib, and vemurafenib. Clinical trials have shown these agents to be effective in treatment of metastatic and locally advanced melanoma, increasing overall and progression-free survival.
Vivian T Yin   +2 more
exaly   +3 more sources

Home - About - Disclaimer - Privacy